Immunohistochemistry (IHC) and western blotting demonstrated that most NPC samples had abnormally positive FGF19 immunoreactivity, while in nasopharyngeal epithelium tissues, FGF19 was downregulated or absent (Fig. 1A-B). The gene discussed is FGF19; the disease is nasopharyngeal carcinoma.